| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,163 |
9,577 |
$1.40M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,435 |
9,230 |
$1.20M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,083 |
9,166 |
$1.09M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,565 |
3,164 |
$570K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,366 |
890 |
$446K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,349 |
1,992 |
$280K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,157 |
2,589 |
$246K |
| 70450 |
Computed tomography, head or brain; without contrast material |
945 |
731 |
$237K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
747 |
554 |
$201K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,165 |
741 |
$197K |
| 59025 |
Fetal non-stress test |
1,122 |
656 |
$164K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
543 |
416 |
$148K |
| G0378 |
Hospital observation service, per hour |
1,557 |
652 |
$123K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,587 |
476 |
$107K |
| 80053 |
Comprehensive metabolic panel |
11,382 |
8,872 |
$94K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
772 |
511 |
$91K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
461 |
407 |
$84K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
373 |
194 |
$83K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
552 |
484 |
$73K |
| 76818 |
|
513 |
223 |
$63K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,454 |
1,351 |
$60K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,392 |
15,375 |
$58K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
361 |
287 |
$56K |
| 73630 |
|
1,280 |
1,065 |
$53K |
| 88143 |
|
2,498 |
2,310 |
$50K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,158 |
1,063 |
$50K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
925 |
298 |
$50K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,829 |
2,466 |
$48K |
| 36415 |
Collection of venous blood by venipuncture |
25,000 |
18,992 |
$45K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,419 |
1,316 |
$39K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
573 |
191 |
$38K |
| 84702 |
|
2,153 |
1,522 |
$35K |
| 76830 |
Ultrasound, transvaginal |
699 |
610 |
$32K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,070 |
1,865 |
$32K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
168 |
145 |
$32K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
274 |
254 |
$31K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,918 |
3,119 |
$29K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,851 |
2,496 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
1,885 |
1,696 |
$22K |
| 73610 |
|
667 |
531 |
$22K |
| 80061 |
Lipid panel |
1,382 |
1,233 |
$22K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
166 |
141 |
$20K |
| 86850 |
|
783 |
668 |
$19K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
150 |
125 |
$16K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,101 |
1,719 |
$16K |
| 87480 |
|
624 |
563 |
$15K |
| 87800 |
|
529 |
516 |
$15K |
| 84439 |
|
733 |
643 |
$15K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
254 |
109 |
$14K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
900 |
652 |
$14K |
| J3490 |
Unclassified drugs |
2,878 |
1,114 |
$13K |
| 93971 |
|
211 |
171 |
$13K |
| 86900 |
|
908 |
761 |
$12K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
120 |
85 |
$12K |
| 84436 |
|
963 |
868 |
$11K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
482 |
417 |
$11K |
| 87660 |
|
624 |
563 |
$10K |
| 86803 |
|
457 |
399 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,709 |
4,742 |
$9K |
| 87150 |
|
569 |
463 |
$8K |
| 86901 |
|
908 |
761 |
$8K |
| 83525 |
|
340 |
295 |
$7K |
| 87510 |
|
624 |
563 |
$7K |
| 87081 |
|
647 |
541 |
$7K |
| 84481 |
|
519 |
454 |
$7K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
80 |
73 |
$7K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
466 |
414 |
$6K |
| 83540 |
|
632 |
569 |
$6K |
| 87340 |
|
296 |
257 |
$6K |
| 74018 |
|
193 |
159 |
$6K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
70 |
25 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,110 |
1,429 |
$6K |
| 84479 |
|
296 |
268 |
$6K |
| 97161 |
|
114 |
94 |
$5K |
| 80076 |
|
484 |
402 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,068 |
1,822 |
$5K |
| 86140 |
|
531 |
417 |
$5K |
| 94667 |
|
31 |
12 |
$5K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
112 |
99 |
$4K |
| 80320 |
|
558 |
408 |
$4K |
| 81001 |
|
3,368 |
2,749 |
$4K |
| 84484 |
|
2,281 |
1,715 |
$4K |
| 87070 |
|
1,081 |
928 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
2,730 |
2,237 |
$4K |
| 86762 |
|
210 |
185 |
$3K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
196 |
192 |
$3K |
| 0001A |
|
106 |
100 |
$3K |
| 85610 |
|
1,274 |
1,001 |
$3K |
| 86592 |
|
256 |
233 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
467 |
332 |
$3K |
| 82607 |
|
158 |
134 |
$3K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
28 |
27 |
$3K |
| 0002A |
|
86 |
81 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
190 |
152 |
$3K |
| 87186 |
|
672 |
525 |
$2K |
| 82728 |
|
171 |
152 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,220 |
972 |
$2K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$2K |
| 83880 |
|
557 |
417 |
$2K |
| 85730 |
|
804 |
647 |
$2K |
| 83735 |
|
731 |
502 |
$2K |
| 85027 |
|
523 |
387 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
302 |
286 |
$2K |
| 87420 |
|
283 |
252 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,174 |
4,185 |
$2K |
| 86593 |
|
171 |
148 |
$2K |
| 81003 |
|
1,923 |
1,545 |
$2K |
| 73030 |
|
107 |
93 |
$2K |
| 82950 |
|
108 |
91 |
$2K |
| 86703 |
|
87 |
81 |
$1K |
| 85652 |
|
451 |
374 |
$1K |
| 84703 |
|
2,129 |
1,645 |
$1K |
| 74022 |
|
140 |
99 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,452 |
1,221 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
144 |
105 |
$1K |
| 73564 |
|
98 |
71 |
$1K |
| 72100 |
|
64 |
52 |
$1K |
| 83605 |
|
1,348 |
922 |
$1K |
| 96367 |
|
40 |
25 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,881 |
2,754 |
$1K |
| 82553 |
|
307 |
206 |
$1K |
| 96376 |
|
841 |
403 |
$1K |
| 73110 |
|
30 |
26 |
$994.90 |
| 87077 |
|
250 |
198 |
$956.47 |
| 83690 |
|
1,691 |
1,238 |
$885.02 |
| 82570 |
|
91 |
69 |
$765.27 |
| 83874 |
|
293 |
213 |
$683.68 |
| 87040 |
|
596 |
251 |
$609.59 |
| 86706 |
|
30 |
28 |
$512.02 |
| 73130 |
|
28 |
24 |
$485.90 |
| 82105 |
|
23 |
19 |
$481.46 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
118 |
102 |
$455.38 |
| 82948 |
|
524 |
336 |
$443.84 |
| 85007 |
|
183 |
143 |
$442.13 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
396 |
325 |
$397.35 |
| 82150 |
|
256 |
168 |
$385.39 |
| 82550 |
|
349 |
239 |
$362.03 |
| 90715 |
|
22 |
12 |
$359.54 |
| 83001 |
|
16 |
13 |
$323.36 |
| 82043 |
|
53 |
45 |
$308.12 |
| 83002 |
|
16 |
13 |
$303.15 |
| 85378 |
|
408 |
324 |
$250.55 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,417 |
1,538 |
$234.67 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
761 |
369 |
$185.03 |
| 84550 |
|
13 |
12 |
$154.35 |
| 73562 |
|
13 |
13 |
$139.24 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
427 |
234 |
$115.18 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
922 |
518 |
$94.11 |
| 81015 |
|
69 |
37 |
$85.43 |
| 84100 |
|
16 |
12 |
$56.22 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,459 |
983 |
$36.94 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
294 |
195 |
$33.77 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
19 |
18 |
$32.02 |
| 80179 |
|
247 |
173 |
$31.28 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,234 |
924 |
$29.51 |
| 80329 |
|
211 |
143 |
$28.59 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
200 |
152 |
$23.67 |
| 83550 |
|
12 |
12 |
$21.09 |
| J1094 |
Injection, dexamethasone acetate, 1 mg |
212 |
145 |
$19.88 |
| J7050 |
Infusion, normal saline solution, 250 cc |
569 |
248 |
$19.22 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
111 |
76 |
$14.01 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
567 |
344 |
$13.13 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,984 |
1,269 |
$10.26 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
898 |
573 |
$10.09 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
558 |
370 |
$9.74 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
180 |
82 |
$6.78 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
106 |
84 |
$4.06 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
73 |
40 |
$3.15 |
| J2704 |
Injection, propofol, 10 mg |
694 |
455 |
$2.13 |
| 91300 |
|
192 |
167 |
$1.61 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
444 |
307 |
$1.40 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
226 |
149 |
$1.02 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
160 |
83 |
$0.85 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
103 |
70 |
$0.57 |
| J3480 |
Injection, potassium chloride, per 2 meq |
28 |
12 |
$0.23 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
20 |
12 |
$0.09 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
287 |
223 |
$0.00 |
| 00840 |
|
52 |
30 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
18 |
12 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
35 |
31 |
$0.00 |
| 82800 |
|
19 |
12 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
30 |
26 |
$0.00 |
| 36416 |
|
16 |
12 |
$0.00 |
| 94761 |
|
212 |
70 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
143 |
85 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
13 |
13 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
22 |
12 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
27 |
15 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
20 |
13 |
$0.00 |